Globe Life, US37959E1029

Globe Life lifts 2026 earnings outlook. Analysts and premium growth stay in view.

30.06.2026 - 14:53:06 | ad-hoc-news.de

Globe Life stock has a fresh catalyst after the insurer raised its full-year 2026 net operating earnings outlook and reported higher premium revenue in its first-quarter update.

Globe Life, US37959E1029
Globe Life, US37959E1029

By Anna Walker, Analysts & Consensus desk. Reviewed on June 30, 2026 at 2:52 p.m. ET.

Globe Life Inc. (US37959E1029) has a new earnings backdrop after the company said first-quarter 2026 net operating income rose 11.7% year over year and lifted full-year guidance to $15.40 to $15.90 per diluted share, according to a Zacks report on the quarter. The stock trades on the NYSE under GL, giving the update a clear US-market anchor.

Quarterly results

The quarter also showed total premium revenues of $1.3 billion, up 6% year over year, with higher premiums from Life and Health insurance supporting the top line, according to the same Zacks report. Globe Life also repurchased 1.4 million shares worth about $203 million during the period, which added another capital-return detail to the update.

That mix matters for investors because the guidance increase came even though the quarter missed the Zacks consensus estimate on a per-share basis. The company said the annual outlook now reflects a stronger operating setup for 2026.

Analyst tone

Coverage around the shares has also stayed active: a Globe Life note on Intellectia AI said TD Cowen raised its price target to $215 from $199 and kept a Buy rating, while Piper Sandler lifted its target to $175 from $167 and kept an Overweight rating. A separate MarketBeat page on Globe Life showed a consensus target price of $175.89 and highlighted the stock's close at $178.94 on June 29, 2026.

For the market, the key issue is whether premium growth and underwriting results keep supporting the earnings run rate that management outlined for 2026. The latest figures suggest that the answer still hinges on execution, not just revenue growth.

What Globe Life sells

Globe Life is an insurance company with life and health products at the center of its model, and the company says premium growth in those lines continues to drive operating performance. That makes the quarter's premium trend more important than a single earnings print.

Shares and valuation

Globe Life shares last closed at $178.94 on June 29, 2026, according to MarketBeat. At that level, the stock sits near the latest consensus target cited there, while the updated earnings range keeps the next reporting cycle relevant for valuation.

Globe Life stock facts

  • Company: Globe Life Inc.
  • ISIN: US37959E1029
  • Ticker: GL
  • Exchange: NYSE
  • Price (as of June 29, 2026, 3:59 p.m. ET): $178.94 USD
  • Market cap: $13.92 billion (as of June 30, 2026)
  • Sector / Industry: Financials / Life & Health Insurance
  • Index membership: not verified in the available results
  • Next earnings date: not yet officially scheduled

Track Globe Life online

This article was generated automatically and technically reviewed before publication. Market prices, analyst data and company information are provided without warranty and may change at short notice. This content is for informational purposes only and is not investment, financial, legal or tax advice. It is not a recommendation to buy or sell any security. Investing in securities involves risk, including the possible loss of principal.

en | US37959E1029 | GLOBE LIFE | boerse | 69661188 | bgmi